These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 33668823)
1. A Comparison of the In Vitro Effects of 2'Fucosyllactose and Lactose on the Composition and Activity of Gut Microbiota from Infants and Toddlers. Van den Abbeele P; Sprenger N; Ghyselinck J; Marsaux B; Marzorati M; Rochat F Nutrients; 2021 Feb; 13(3):. PubMed ID: 33668823 [TBL] [Abstract][Full Text] [Related]
2. The effect of 2'-fucosyllactose on simulated infant gut microbiome and metabolites; a pilot study in comparison to GOS and lactose. Salli K; Anglenius H; Hirvonen J; Hibberd AA; Ahonen I; Saarinen MT; Tiihonen K; Maukonen J; Ouwehand AC Sci Rep; 2019 Sep; 9(1):13232. PubMed ID: 31520068 [TBL] [Abstract][Full Text] [Related]
3. Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro. Natividad JM; Marsaux B; Rodenas CLG; Rytz A; Vandevijver G; Marzorati M; Van den Abbeele P; Calatayud M; Rochat F Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745275 [TBL] [Abstract][Full Text] [Related]
4. Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics. Berger B; Porta N; Foata F; Grathwohl D; Delley M; Moine D; Charpagne A; Siegwald L; Descombes P; Alliet P; Puccio G; Steenhout P; Mercenier A; Sprenger N mBio; 2020 Mar; 11(2):. PubMed ID: 32184252 [TBL] [Abstract][Full Text] [Related]
5. Effects of Human Milk Oligosaccharides on the Adult Gut Microbiota and Barrier Function. Šuligoj T; Vigsnæs LK; Abbeele PVD; Apostolou A; Karalis K; Savva GM; McConnell B; Juge N Nutrients; 2020 Sep; 12(9):. PubMed ID: 32933181 [TBL] [Abstract][Full Text] [Related]
6. HMOs Exert Marked Bifidogenic Effects on Children's Gut Microbiota Ex Vivo, Due to Age-Related Bajic D; Wiens F; Wintergerst E; Deyaert S; Baudot A; Van den Abbeele P Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049541 [TBL] [Abstract][Full Text] [Related]
7. Distinct fermentation of human milk oligosaccharides 3-FL and LNT2 and GOS/inulin by infant gut microbiota and impact on adhesion of Kong C; Akkerman R; Klostermann CE; Beukema M; Oerlemans MMP; Schols HA; de Vos P Food Funct; 2021 Dec; 12(24):12513-12525. PubMed ID: 34811557 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the Bifidogenic Effects of Goat and Cow Milk-Based Infant Formulas to Human Breast Milk in an Gallier S; Van den Abbeele P; Prosser C Front Nutr; 2020; 7():608495. PubMed ID: 33363198 [TBL] [Abstract][Full Text] [Related]
9. Breastfeeding and the major fermentation metabolite lactate determine occurrence of Huertas-Díaz L; Kyhnau R; Ingribelli E; Neuzil-Bunesova V; Li Q; Sasaki M; Lauener RP; Roduit C; Frei R; Study Group CC; Sundekilde U; Schwab C Gut Microbes; 2023; 15(1):2241209. PubMed ID: 37592891 [TBL] [Abstract][Full Text] [Related]
10. Human Milk Oligosaccharides: Factors Affecting Their Composition and Their Physiological Significance. Sprenger N; Binia A; Austin S Nestle Nutr Inst Workshop Ser; 2019; 90():43-56. PubMed ID: 30865976 [TBL] [Abstract][Full Text] [Related]
11. 2'-Fucosyllactose (2'-FL) changes infants gut microbiota composition and their metabolism in a host-free human colonic model. Zhang S; Chen L; Hu M; Zhu J Food Res Int; 2023 Nov; 173(Pt 1):113293. PubMed ID: 37803605 [TBL] [Abstract][Full Text] [Related]
12. Oligofructose, 2'fucosyllactose and β-glucan in combination induce specific changes in microbial composition and short-chain fatty acid production compared to sole supplementation. Jackson PPJ; Wijeyesekera A; van Harsselaar J; Theis S; Rastall RA J Appl Microbiol; 2023 Feb; 134(2):. PubMed ID: 36724263 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of a probiotic-containing infant formula supplemented with 2'-fucosyllactose: a double-blind randomized controlled trial. Alliet P; Vandenplas Y; Roggero P; Jespers SNJ; Peeters S; Stalens JP; Kortman GAM; Amico M; Berger B; Sprenger N; Cercamondi CI; Corsello G Nutr J; 2022 Feb; 21(1):11. PubMed ID: 35193609 [TBL] [Abstract][Full Text] [Related]
14. Effect of Bifidobacterium crudilactis and 3'-sialyllactose on the toddler microbiota using the SHIME® model. Bondue P; Lebrun S; Taminiau B; Everaert N; LaPointe G; Hendrick C; Gaillez J; Crèvecoeur S; Daube G; Delcenserie V Food Res Int; 2020 Dec; 138(Pt A):109755. PubMed ID: 33292938 [TBL] [Abstract][Full Text] [Related]
15. Effects of 2'-fucosyllactose on the composition and metabolic activity of intestinal microbiota from piglets after in vitro fermentation. Zhang Y; Ye Y; Guo J; Wang M; Li X; Ren Y; Zhu W; Yu K J Sci Food Agric; 2024 Feb; 104(3):1553-1563. PubMed ID: 37815100 [TBL] [Abstract][Full Text] [Related]
16. Gram-scale chemical synthesis of galactosyllactoses and their impact on infant gut microbiota Meeusen E; Cao L; Delsing DJ; Groeneveld A; Heerikhuisen M; Schuren F; Boltje TJ Org Biomol Chem; 2024 Mar; 22(10):2091-2097. PubMed ID: 38363206 [TBL] [Abstract][Full Text] [Related]
17. Varied Pathways of Infant Gut-Associated Sakanaka M; Gotoh A; Yoshida K; Odamaki T; Koguchi H; Xiao JZ; Kitaoka M; Katayama T Nutrients; 2019 Dec; 12(1):. PubMed ID: 31888048 [TBL] [Abstract][Full Text] [Related]
18. The human milk oligosaccharides 2'-fucosyllactose and 6'-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling. Sodhi CP; Wipf P; Yamaguchi Y; Fulton WB; Kovler M; Niño DF; Zhou Q; Banfield E; Werts AD; Ladd MR; Buck RH; Goehring KC; Prindle T; Wang S; Jia H; Lu P; Hackam DJ Pediatr Res; 2021 Jan; 89(1):91-101. PubMed ID: 32221473 [TBL] [Abstract][Full Text] [Related]
19. Correlations between oligosaccharides in breast milk and the composition of the gut microbiome in breastfed infants. Shang J; Yang S; Meng X J Dairy Sci; 2022 Jun; 105(6):4818-4828. PubMed ID: 35400500 [TBL] [Abstract][Full Text] [Related]
20. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome. Iribarren C; Magnusson MK; Vigsnæs LK; Aziz I; Amundsen ID; Šuligoj T; Juge N; Patel P; Sapnara M; Johnsen L; Sørensen N; Sundin J; Törnblom H; Simrén M; Öhman L Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]